Horizon Therapeutics [HZNP] vs Johnson & Johnson [JNJ] Detailed Stock Comparison

Horizon Therapeutics

NASDAQ

Johnson & Johnson

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Horizon Therapeutics wins in 5 metrics, Johnson & Johnson wins in 12 metrics, with 0 ties. Johnson & Johnson appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Horizon Therapeutics	Johnson & Johnson	Better
P/E Ratio (TTM)	61.86	19.16	Johnson & Johnson
Price-to-Book Ratio	5.01	5.49	Horizon Therapeutics
Debt-to-Equity Ratio	0.48	64.69	Horizon Therapeutics
PEG Ratio	-16.29	1.07	Horizon Therapeutics
EV/EBITDA	24.08	15.30	Johnson & Johnson
Profit Margin (TTM)	74.64%	25.00%	Horizon Therapeutics
Operating Margin (TTM)	16.83%	28.91%	Johnson & Johnson
EBITDA Margin (TTM)	16.83%	28.91%	Johnson & Johnson
Return on Equity	10.28%	30.21%	Johnson & Johnson
Return on Assets (TTM)	5.72%	7.61%	Johnson & Johnson
Free Cash Flow (TTM)	N/A	$18.06B	N/A
Dividend Yield	N/A	2.47%	N/A
1-Year Return	-6.82%	9.24%	Johnson & Johnson
Price-to-Sales Ratio (TTM)	7.34	4.75	Johnson & Johnson
Enterprise Value	$26.84B	$462.81B	Johnson & Johnson
EV/Revenue Ratio	7.40	5.11	Johnson & Johnson
Gross Profit Margin (TTM)	76.72%	67.87%	Horizon Therapeutics
Revenue per Share (TTM)	$16	$38	Johnson & Johnson
Earnings per Share (Diluted)	$2.22	$9.34	Johnson & Johnson
Beta (Stock Volatility)	N/A	0.40	N/A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Horizon Therapeutics vs Johnson & Johnson Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Horizon Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Johnson & Johnson	0.20%	1.50%	6.76%	17.48%	9.50%	24.49%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Horizon Therapeutics	-6.82%	74.04%	9.84%	176.66%	176.66%	176.66%
Johnson & Johnson	9.24%	9.14%	16.69%	88.39%	211.27%	189.46%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Horizon Therapeutics (HZNP): View Full Stock Overview

Johnson & Johnson (JNJ): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Horizon Therapeutics vs Johnson & Johnson

Metric	HZNP	JNJ
Market Information
Market Cap i	$26.63B	$430.92B
Market Cap Category	Large cap	Mega cap
10 Day Avg. Volume i	19,134,206	8,290,450
90 Day Avg. Volume i	8,460,695	9,094,253
Last Close	$116.30	$179.29
52 Week Range	$116.30 - $116.34	$140.68 - $181.16
% from 52W High	-0.03%	-1.03%
All-Time High	$39.49 (Jul 20, 2015)	$186.69 (Apr 25, 2022)
% from All-Time High	194.50%	-3.96%
Growth Metrics
Quarterly Revenue Growth	0.14%	0.06%
Quarterly Earnings Growth	N/A	0.18%
Financial Health
Profit Margin (TTM) i	0.75%	0.25%
Operating Margin (TTM) i	0.17%	0.29%
Return on Equity (TTM) i	0.10%	0.30%
Debt to Equity (MRQ) i	0.48	64.69
Cash & Liquidity
Book Value per Share (MRQ)	$23.22	$32.61
Cash per Share (MRQ)	N/A	$7.84
Operating Cash Flow (TTM) i	$1.33B	$23.03B
Levered Free Cash Flow (TTM) i	$1.81B	$11.08B
Dividends
Last 12-Month Dividend Yield i	N/A	2.47%
Last 12-Month Dividend i	N/A	$3.72

Valuation & Enterprise Metrics Analysis: Horizon Therapeutics vs Johnson & Johnson

Metric	HZNP	JNJ
Price Ratios
P/E Ratio (TTM) i	61.86	19.16
Forward P/E i	20.55	16.88
PEG Ratio i	-16.29	1.07
Price to Sales (TTM) i	7.34	4.75
Price to Book (MRQ) i	5.01	5.49
Market Capitalization
Market Capitalization i	$26.63B	$430.92B
Enterprise Value i	$26.84B	$462.81B
Enterprise Value Metrics
Enterprise to Revenue i	7.40	5.11
Enterprise to EBITDA i	24.08	15.30
Risk & Other Metrics
Beta i	N/A	0.40
Book Value per Share (MRQ) i	$23.22	$32.61

Financial Statements Comparison: Horizon Therapeutics vs Johnson & Johnson

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	HZNP	JNJ
Revenue/Sales i	N/A	$21.89B
Cost of Goods Sold i	N/A	$7.36B
Gross Profit i	N/A	$14.54B
Research & Development i	N/A	$3.23B
Operating Income (EBIT) i	N/A	$6.30B
EBITDA i	N/A	$8.72B
Pre-Tax Income i	N/A	$13.63B
Income Tax i	N/A	$2.63B
Net Income (Profit) i	N/A	$11.00B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	HZNP	JNJ
Cash & Equivalents i	N/A	$38.47B
Total Current Assets i	N/A	$71.55B
Total Current Liabilities i	N/A	$56.90B
Long-Term Debt i	N/A	$38.36B
Total Shareholders Equity i	N/A	$78.11B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	N/A	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	HZNP	JNJ
Operating Cash Flow i	N/A	$6.35B
Capital Expenditures i	N/A	$-795.00M
Free Cash Flow i	N/A	$3.37B
Debt Repayment i	N/A	$-2.87B
Common Stock Repurchase i	N/A	$-2.13B

Short Interest & Institutional Ownership Analysis

Metric	HZNP	JNJ
Shares Short i	N/A	17.14M
Short Ratio i	N/A	2.00
Short % of Float i	N/A	0.01%
Average Daily Volume (10 Day) i	19,134,206	8,290,450
Average Daily Volume (90 Day) i	8,460,695	9,094,253
Shares Outstanding i	229.00M	2.41B
Float Shares i	N/A	2.40B
% Held by Insiders i	N/A	0.00%
% Held by Institutions i	N/A	0.74%

Dividend Analysis & Yield Comparison: Horizon Therapeutics vs Johnson & Johnson

Metric	HZNP	JNJ
Last 12-Month Dividend i	N/A	$3.72
Last 12-Month Dividend Yield i	N/A	2.47%
3-Year Avg Annual Dividend i	N/A	$3.97
3-Year Avg Dividend Yield i	N/A	0.75%
3-Year Total Dividends i	N/A	$11.92
Ex-Dividend Date	N/A	Feb 18, 2025

Horizon Therapeutics [HZNP] vs Johnson & Johnson [JNJ] Detailed Stock Comparison